呼吸道感染患儿肺炎支原体IgM抗体检测结果分析

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (483 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨呼吸道感染患儿肺炎支原体(mycoplasma pneumoniae,MP)阳性率与性别、季节、年龄和年度的关系,了解患儿感染肺炎支原体的流行趋势,为临床提供预防和治疗的依据。方法对2013-01至2015-12武警广东总队医院3011例血清样本MP-IgM抗体检测结果进行回顾性分析。结果男性患儿MP-IgM阳性率为19.53%,女性患儿MP-IgM阳性率为26.76%,两组对比差异有统计学意义(P<0.01);MP-IgM阳性率在不同年龄段和季节组之间差异有统计学意义(P<0.05),以3~<6岁、第一季度高发;2013、2014、2015年MP-IgM阳性率分别为32.99%、20.20%、11.21%,差异有统计学意义(P<0.01)。结论肺炎支原体感染存在性别、年龄、季节和年度流行差异,第一季度、3~6岁女性患儿为高发,应有针对性地进行重点检测与防治。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	李玉华
	朱正林
	贾宁宁³

关键词 ：肺炎支原体, 抗体, 酶联免疫法

Abstract：Objective To study the correlation between the positive rate of mycoplasma pneumonia with gender, age, the season and year in children with respiratory tract infection in order to provide reference for prevention and clinical treatment.Methods 3011 serum samples detected with MP-IgM antibody between 2013 and 2015 were retrospectively analyzed. The relationship between the positive rate of MP-IgM antibody and gender, age, the season and year was studied.Results The positive rate of MP-IgM antibody was 19.53% among male children, and 26.76% among female children. There was statistically significant difference between the two groups (P<0.01). There was statistically significant difference in the positive rate of MP-IgM antibody between different age groups and season groups(P<0.05). The 3～<6 years group and the first season group had the highest positive rates. The positive rate of MP-IgM antibody in 2013, 2014 and 2015 was 32.99%,20.20%,and 11.21% respectively, and the difference was of statistical significance (P<0.01).Conclusions Mycoplasma pneumonia infection is related to gender,age,seasons and years. In the first season,female children aged three to six should be taken good care of.

Key words： mycoplasma pneumoniae antibody ELISA

收稿日期: 2016-05-31

ZTFLH:

R563.1

通讯作者: 朱正林,E-mail:zhengling8710@sina.com

作者简介: 李玉华,本科学历,主管技师。

引用本文:

李玉华,朱正林,贾宁宁³

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2017/V28/I1/16

[1]	曾敏,胡金刚.小儿支原体肺炎95例[J].武警医学,2012,23(6):521-522.
[2]	朱清义,徐静,刘敬东.青岛市小儿肺炎支原体流行病学分析[J].中华医院感染学杂志,2004,14(3):248-250.
[3]	谷丽,杨蓉,陆凤凤.阿奇霉素治疗小儿支原体性肺炎临床效果观察[J].中华医院感染学杂志,2016,16(4):440-441.
[4]	Cimolai N,Cheong A C.An assessment of a new diagnostic indirect enzyme immunoassay foe the detection of anti mycoplasma peneumoniae IgM[J]. Am J Clin Panthod,1996,105(2): 205-209.
[5]	中华医学会儿科学分会呼吸学组《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[6]	李明芬,韦巍,黄永升,等.南宁市肺炎支原体IgM抗体检测分析[J].右江民族医学院学报,2014,36(3):442-444.
[7]	黄海樱,陈波,周强.广州地区肺炎支原体感染儿童血清流行病学调查分析[J].中国儿童保健杂志,2014,22(1):83-84.
[8]	崔京涛,吴叶丽,李倩,等.肺炎支原体感染者血清流行病学分析及其抗菌药物疗效评价[J].中华检验医学杂志,2011,23(9):820-823.
[9]	Polkowska A,Harjunp A,Toikkanen S, et al.Increased incidence of Mycoplasma pneumoniae infection in Finland,2010-2011[J].Euro Surveill,2012,17(5): 20072.
[10]	Jaeobs E.Mycoplasma pneumoniae:now in the focus of clinicians and epidemiologists[J].Euro Surveill,2012,17(6): 20084.